(Chicago, IL) March 31, 2002 -- Rakesh Amin, a partner at the Chicago, IL-based law firm of Weaver & Amin and well-known expert in Food and Drug Administration (FDA) and Federal Trade Commission (FTC) state and federal regulatory and litigation issues, has kicked-off a series of U.S. and international seminar appearances to discuss dietary supplement industry issues.
Appearing at the Weight Loss Products Conference held at the Chicago Hilton on February 26, Amin focused on “FDA & FTC Regulatory Issues in Today's Weight Loss Market.” He discussed how the recent ephedra issues unfolded and how half-truths and innuendo have curtailed its use as a weight loss ingredient. During his presentation, he addressed other popular diet ingredients and topics such as nutrient content claims, health claims, structure-function claims, product liability, civil litigation, current State, Federal, FDA, FTC and international regulatory positions, USP certification and trends in the natural products industry regarding formulating and marketing alternative weight loss products.
Amin’s second presentation covered “Functional Foods, U.S. Perspective” at the Functional Foods 2002 Conference on March 5-7, at The Hague, Netherlands. Amin discussed how functional foods are defined and regulated in the U.S. with an emphasis on product development as it relates to regulatory pathway selection. The presentation provided a detailed analysis of U.S. functional food regulatory considerations including GRAS and food additive issues and its impact on product marketing. Amin also gave an overview of FDA enforcement actions associated with functional food products.
Amin is scheduled to appear at the NNFA-Midwest seminar being held in Louisville, KY in April to discuss “DSHEA, Recent Nutraceutical Regulatory Updates and the Benefits of Third-Party Literature” and as a panelist of the functional food/beverage seminar at the Virgo Publishing SupplySide East Conference in May at Secaucus, NJ. Weaver & Amin concentrates its practice in Food and Drug Administration, Federal Trade Commission, and related Federal and State regulatory compliance and litigation matters, contracts and business transactions, and intellectual property prosecution, maintenance, licensing, and litigation. The firm's practice also includes the regulation of many consumer products such as cosmetics, medical devices, dietary supplements, food additives, organics, nutraceuticals, color additives, animal feeds, and biologics. A significant component of the practice involves new product labeling, clinical testing protocols, advertising, and legal and regulatory review of health claims and statements of nutritional support. For more information contact Weaver & Amin at (312) 701-0844 or visit the firm’s web site at www.weaveramin.com.